A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002. (Q38864811)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 June 2016

Language	Label	Description	Also known as
English	A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.	scientific article published on 14 June 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymph node metastasis

1 reference

based on heuristic

inferred from title

Daisuke Takahari

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Seiji Ito

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

Takeshi Sano

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

Junki Mizusawa

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

Hiroshi Katayama

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

Hitoshi Katai

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

Yoshiyuki Kawashima

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

Takahiro Kinoshita

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

Masanori Terashima

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

Atsushi Nashimoto

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

Mikihito Nakamori

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

Hiroaki Onaya

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

Mitsuru Sasako

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

publication date

14 June 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

322-331

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27299887 AND SRC:MED&resulttype=core&format=json

13 March 2020

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://api.crossref.org/works/10.1007/S10120-016-0619-Z

21 January 2018

Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement.

1 reference

https://api.crossref.org/works/10.1007/S10120-016-0619-Z

21 January 2018

Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1007/S10120-016-0619-Z

21 January 2018

Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis

1 reference

https://api.crossref.org/works/10.1007/S10120-016-0619-Z

21 January 2018

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

https://api.crossref.org/works/10.1007/S10120-016-0619-Z

21 January 2018

Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.

1 reference

https://api.crossref.org/works/10.1007/S10120-016-0619-Z

21 January 2018

A multicenter, phase I dose-escalating study of docetaxel, cisplatin and S-1 for advanced gastric cancer (KDOG0601).

1 reference

https://api.crossref.org/works/10.1007/S10120-016-0619-Z

21 January 2018

Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.

1 reference

https://api.crossref.org/works/10.1007/S10120-016-0619-Z

21 January 2018

Japanese gastric cancer treatment guidelines 2010 (ver. 3)

1 reference

https://api.crossref.org/works/10.1007/S10120-016-0619-Z

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1007/S10120-016-0619-Z

21 January 2018

Impact of excision repair cross-complementing gene 1 (ERCC1) on the outcomes of patients with advanced gastric cancer: correlative study in Japan Clinical Oncology Group Trial JCOG9912.

1 reference

https://api.crossref.org/works/10.1007/S10120-016-0619-Z

21 January 2018

A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis

1 reference

https://api.crossref.org/works/10.1007/S10120-016-0619-Z

21 January 2018

Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A).

1 reference

https://api.crossref.org/works/10.1007/S10120-016-0619-Z

21 January 2018

NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/27299887

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501

1 reference

https://pubmed.ncbi.nlm.nih.gov/27299887

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of the optimal cutoff percentage of residual tumors to define the pathological response rate for gastric cancer treated with preoperative therapy (JCOG1004-A)

1 reference

https://pubmed.ncbi.nlm.nih.gov/27299887

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of multimodality treatment: two and four courses of neoadjuvant chemotherapy using S-1/CDDP or S-1/CDDP/docetaxel followed by surgery and S-1 adjuvant chemotherapy for macroscopically resectable serosa-positive gastric cancer: a randomi

1 reference

https://pubmed.ncbi.nlm.nih.gov/27299887

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Japanese classification of gastric carcinoma: 3rd English edition

1 reference

https://pubmed.ncbi.nlm.nih.gov/27299887

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27299887

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601)

1 reference

https://pubmed.ncbi.nlm.nih.gov/27299887

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of Histopathological Tumor Regression After Neoadjuvant Chemotherapy in Gastric Adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/27299887

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38864811&oldid=2202198857"